Hyundai Pharm (004310) — Cash Flow Reinvestment Rate
Hyundai Pharm (004310) has a Cash Flow Reinvestment Rate of 14.79x as of February 2026, reinvesting ₩2.78 Billion (capex ₩2.59 Billion plus investments ₩192.05 Million) from operating cash flow of ₩188.28 Million. Explore Hyundai Pharm (004310) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hyundai Pharm Cash Flow Reinvestment Rate (2010–2022)
Historical reinvestment intensity for Hyundai Pharm across 8 annual periods. Also explore 004310 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hyundai Pharm (2010–2022)
Year-by-year capital reinvestment analysis for Hyundai Pharm. For live market cap and broader valuation context, see Hyundai Pharm market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.43x | ₩16.57 Billion | ₩11.62 Billion | ₩6.58 Billion | ▲ +7.0% |
| 2021 | 1.33x | ₩6.84 Billion | ₩5.13 Billion | ₩6.81 Billion | ▼ -23.4% |
| 2020 | 1.74x | ₩18.79 Billion | ₩10.80 Billion | ₩6.40 Billion | ▲ +138.0% |
| 2019 | 0.73x | ₩5.09 Billion | ₩6.96 Billion | ₩2.36 Billion | ▼ -74.6% |
| 2018 | 2.87x | ₩8.14 Billion | ₩2.83 Billion | ₩2.67 Billion | ▲ +727.5% |
| 2013 | 0.35x | ₩2.76 Billion | ₩7.95 Billion | ₩2.24 Billion | ▼ -45.2% |
| 2011 | 0.63x | ₩3.97 Billion | ₩6.27 Billion | ₩3.68 Billion | ▼ -58.9% |
| 2010 | 1.54x | ₩4.13 Billion | ₩2.68 Billion | ₩3.95 Billion | — |